Results 141 to 150 of about 48,095 (189)
Mechanism and modification of rejection of heterografts between divergent species. [PDF]
Amemiya, H+9 more
core
Abstract Aims Early diuresis and natriuresis are commonly used to assess the efficacy of decongestive therapy following an acute heart failure episode. There is limited knowledge regarding which parameter better predicts adverse clinical outcomes, especially in the outpatient setting.
M. Cobo Marcos+15 more
wiley +1 more source
Purinergic Receptor Activation Protects Glomerular Microvasculature from Increased Mechanical Stress in Angiotensin II-Induced Hypertension: A Modeling Study. [PDF]
Richfield O+4 more
europepmc +1 more source
Iron deficiency in heart failure: Epidemiology, diagnostic criteria and treatment modalities
ESC Heart Failure, Volume 12, Issue 2, Page 723-726, April 2025.
Stephan von Haehling
wiley +1 more source
Signs of congestion, quality of life and short‐term rehospitalization in patients with heart failure
Abstract Aims Signs of congestion are a treatment target in patients with heart failure (HF), as they affect patients' well‐being, and congestion scores are associated with the risk of early readmission. However, which individual sign of congestion has the strongest association with quality of life (QoL) and HF rehospitalization remains uncertain ...
Geert H.D. Voordes+4 more
wiley +1 more source
Prenatal morphogenic and histogenic development of the kidney in rabbits (<i>Oryctolagus cuniculus</i>). [PDF]
Aref M+5 more
europepmc +1 more source
Abstract Sodium‐glucose cotransporter‐2 (SGLT2) inhibitors represent one of the main cornerstones of heart failure treatment. Nevertheless, while the cardiovascular beneficial effects of these drugs have been clearly demonstrated by several clinical trials, in clinical practice, it remains challenging to identify the appropriate timing to start SGLT2 ...
Ruggero Mazzotta+10 more
wiley +1 more source
Effects of iopromide contrast agents on kidney iNOS expression and tubular histopathology alterations. [PDF]
Pranoto IW+3 more
europepmc +1 more source
Abstract Background Sodium glucose co‐transporter 2 inhibitors (SGLT2i) and mineralocorticoid receptor antagonists (MRA) reduce heart failure (HF) events in patients with heart failure and mildly reduced or preserved ejection fraction (HFmr/pEF). The randomized comparison of SGLT2i/MRA combination versus SGLT2i or MRA alone requires further testing in ...
João Pedro Ferreira+26 more
wiley +1 more source
A red fluorescent lifeact marker to study actin morphology in podocytes. [PDF]
Wiesner E+9 more
europepmc +1 more source